TKM-Ebola approved by the U.S FDA

After the use of the experimental drug Zmapp on two US workers in Liberia, the U.S Food and Drug Administration (FDA) has to a limited extent approved a second meditation. The drug TKM-Ebola has been approved from the next phase of clinical trials.
Read more Second experimental ebola drug gains approval.